A high prevalence of vascular calcification (VC) and a high incidence of cardiovascular
events are two key complications of chronic kidney disease. Since most observational …

Chronic kidney disease (CKD) is a public health epidemic that affects millions of people
worldwide. Presence of CKD predisposes individuals to high risks of end-stage renal …

Soft-tissue calcification is a prominent feature in both chronic kidney disease (CKD) and
experimental Klotho deficiency, but whether Klotho deficiency is responsible for the …

Background Fibroblast growth factor 23 (FGF-23) is a hormone that increases the rate of
urinary excretion of phosphate and inhibits renal production of 1, 25-dihydroxyvitamin D …

†European guidelines on cardiovascular disease prevention in clinical practice: executive
summary | European Heart Journal | Oxford Academic Skip to Main Content Advertisement …

The importance of phosphate homeostasis in chronic kidney disease (CKD) has been
recognized for decades, but novel insights—which are frequently relevant to everyday …

Background Phosphate binders are used to reduce positive phosphate balance and to lower
serum phosphate levels for people with chronic kidney disease (CKD) with the aim to …

Background: Conflicting evidence exists regarding potential cardiovascular risks associated
with high levels of calcium intake. Purpose: To update and reanalyze 2 systematic reviews to …

Magnesium reduces vascular smooth muscle cell (VSMC) calcification in vitro but the
mechanism has not been revealed so far. This work used only slightly increased magnesium …

Patients with chronic kidney disease (CKD) represent an important segment of the
population (7–10%) and, mostly because of the high risk of cardiovascular complications …